当前位置：
X-MOL 学术
›
Hum. Gene Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Institutional Framework for the Management of Human Genetic Resources in China
Human Gene Therapy ( IF 3.9 ) Pub Date : 2021-12-16 , DOI: 10.1089/hum.2021.096 Wei Li 1 , Jiajv Chen 2
Human Gene Therapy ( IF 3.9 ) Pub Date : 2021-12-16 , DOI: 10.1089/hum.2021.096 Wei Li 1 , Jiajv Chen 2
Affiliation
China has made efforts toward the preservation and utilization of human genetic resources (HGRs). In recent years, in the face of various issues that have become increasingly prominent in HGR research, China has continuously strengthened legislation and ethics, and has initially established a relatively complete legal system and ethical guidelines. In the design of regulatory responsibilities, a multisectoral linkage of the Ministry of Science and Technology (MOST), the National Health Commission (NHC), the National Medical Products Administration (NMPA), and the National Intellectual Property Administration (CNIPA) has been formed. In the supervision system, it includes a three-tier structure of Laws/Acts-Regulations-Guidance. In terms of management content, it mainly draws on the basic principles of international conventions such as the Convention on Biological Diversity (CBD), and implements examination and approval filing management and ethical supervision of HGR research in China.
更新日期：2021-12-22
京公网安备 11010802027423号